Robert Califf addressed a range of issues, including AI, lack of nutrition resources at the FDA and how he evaluates the progress of precision medicine at the Precision Medicine World Conference in ...
In a new brief, the Purchaser Business Group on Health called for policy changes that address healthcare costs and improve access to high-quality care.
For about half a decade now, Americans have had the ability to receive controlled substances via telehealth because requirements were relaxed during the Covid-19 pandemic. This has greatly ...
In 2025, primary care practices must navigate a landscape filled with hidden costs that threaten both financial stability and quality of care. From fragmented systems to increasing clinician and ...
When I look back on my journey, I’m reminded of how much can change when you are able to ask for, and receive, help. My name is Dr. Christopher Schenewerk. I am a physician, a father, and a ...
Drugs that activate the GLP-1 receptor transformed the treatment of obesity, but biotech company Metsera contends that limitations keep them from expanding their reach. The weekly injections and ...
Organizations are integrating previously disparate services to better align their offerings with the shift from fee-for-service to risk-based care through visionary, member-centric solutions.
Breakthroughs in physics have reshaped everything from communications to consumer electronics. Yet these methods remain rare in medical practice, where healthcare costs continue to climb, and ...
Welcome back to another episode of MedCity FemFwd, a podcast dedicated to discussing the breakthroughs and challenges in women’s health. In this episode, we’re joined by Emily Lindemer, an ...
While large-molecule therapeutics capture most headlines, small-molecule drugs face significant challenges, struggling with funding cuts, supply chain disruptions, and growing demand. At the same ...
A novel Vertex Pharmaceuticals drug that takes a new approach to pain is now approved by the FDA, a landmark decision for a first-in-class product that brings patients a treatment alternative ...
Insurers of qualified health plans on HealthCare.gov denied about one in five in-network claims and 37% of out-of-network claims in 2023, according to a new analysis from KFF. KFF is a nonprofit ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果